Obianda, Anna Mae T.
HRN: 20-40-41 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2022
CEFUROXIME 1.5GM (VIAL)
05/24/2022
05/24/2022
IVT
1.5G
LD
For CS
Waiting Final Action
05/24/2022
CEFUROXIME 500MG (TAB)
05/24/2022
05/31/2022
ORAL
500mg
Q12
Thick MSAF
Waiting Final Action